Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raymond R Townsend

Showing results (261-270 of 316) with videos related to

Pageof 32
Sort By:
Clinical Journal of the American Society of Nephrology : CJASN|May 10, 2014
Retinopathy and progression of CKD: The CRIC studyJuan E Grunwald, Maxwell Pistilli, Gui-Shuang Ying, et al.
Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation|April 7, 2012
Plant protein intake is associated with fibroblast growth factor 23 and serum bicarbonate levels in patients with chronic kidney disease: the Chronic Renal Insufficiency Cohort studyJulia J Scialla, Lawrence J Appel, Myles Wolf, et al.
Clinical Journal of the American Society of Nephrology : CJASN|February 25, 2018
Central Blood Pressure and Cardiovascular Outcomes in Chronic Kidney DiseaseMahboob Rahman, Jesse Yenchih Hsu, Niraj Desai, et al.
The American Journal of Cardiology|September 28, 2015
Retinopathy and the risk of cardiovascular disease in patients with chronic kidney disease (from the Chronic Renal Insufficiency Cohort study)Juan E Grunwald, Maxwell Pistilli, Gui-Shuang Ying, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 18, 2020
Adiposity, Physical Function, and Their Associations With Insulin Resistance, Inflammation, and Adipokines in CKDSankar D Navaneethan, John P Kirwan, Erick M Remer, et al.
Kidney Medicine|November 2, 2023
Fibroblast Growth Factor 23 and Risk of Heart Failure Subtype: The CRIC (Chronic Renal Insufficiency Cohort) StudyAlexander S Leidner, Xuan Cai, Leila R Zelnick, et al.
Kidney International|March 11, 2011
Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney diseaseTamara Isakova, Patricia Wahl, Gabriela S Vargas, et al.
Hypertension (Dallas, Tex. : 1979)|February 5, 2024
Impact of Antihypertensive Medication Changes After Renal Denervation Among Different Patient Groups: SPYRAL HTN-ON MEDRaymond R Townsend, Keith C Ferdinand, David E Kandzari, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 15, 2018
Use of Measures of Inflammation and Kidney Function for Prediction of Atherosclerotic Vascular Disease Events and Death in Patients With CKD: Findings From the CRIC StudyRichard L Amdur, Harold I Feldman, Elizabeth A Dominic, et al.
Lancet (London, England)|April 7, 2022
Long-term efficacy and safety of renal denervation in the presence of antihypertensive drugs (SPYRAL HTN-ON MED): a randomised, sham-controlled trialFelix Mahfoud, David E Kandzari, Kazuomi Kario, et al.
Pageof 32

Showing results (261-270 of 316) with videos related to

Sort By:
Pageof 32
Clinical Journal of the American Society of Nephrology : CJASN|May 10, 2014
Retinopathy and progression of CKD: The CRIC studyJuan E Grunwald, Maxwell Pistilli, Gui-Shuang Ying, et al.
Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation|April 7, 2012
Plant protein intake is associated with fibroblast growth factor 23 and serum bicarbonate levels in patients with chronic kidney disease: the Chronic Renal Insufficiency Cohort studyJulia J Scialla, Lawrence J Appel, Myles Wolf, et al.
Clinical Journal of the American Society of Nephrology : CJASN|February 25, 2018
Central Blood Pressure and Cardiovascular Outcomes in Chronic Kidney DiseaseMahboob Rahman, Jesse Yenchih Hsu, Niraj Desai, et al.
The American Journal of Cardiology|September 28, 2015
Retinopathy and the risk of cardiovascular disease in patients with chronic kidney disease (from the Chronic Renal Insufficiency Cohort study)Juan E Grunwald, Maxwell Pistilli, Gui-Shuang Ying, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 18, 2020
Adiposity, Physical Function, and Their Associations With Insulin Resistance, Inflammation, and Adipokines in CKDSankar D Navaneethan, John P Kirwan, Erick M Remer, et al.
Kidney Medicine|November 2, 2023
Fibroblast Growth Factor 23 and Risk of Heart Failure Subtype: The CRIC (Chronic Renal Insufficiency Cohort) StudyAlexander S Leidner, Xuan Cai, Leila R Zelnick, et al.
Kidney International|March 11, 2011
Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney diseaseTamara Isakova, Patricia Wahl, Gabriela S Vargas, et al.
Hypertension (Dallas, Tex. : 1979)|February 5, 2024
Impact of Antihypertensive Medication Changes After Renal Denervation Among Different Patient Groups: SPYRAL HTN-ON MEDRaymond R Townsend, Keith C Ferdinand, David E Kandzari, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 15, 2018
Use of Measures of Inflammation and Kidney Function for Prediction of Atherosclerotic Vascular Disease Events and Death in Patients With CKD: Findings From the CRIC StudyRichard L Amdur, Harold I Feldman, Elizabeth A Dominic, et al.
Lancet (London, England)|April 7, 2022
Long-term efficacy and safety of renal denervation in the presence of antihypertensive drugs (SPYRAL HTN-ON MED): a randomised, sham-controlled trialFelix Mahfoud, David E Kandzari, Kazuomi Kario, et al.
Pageof 32